english.prescrire.org > Topics > Advancing healthcare policy > Why You Should Be Concerned About TTIP and Access to Medicines (2/2016)
Advancing healthcare policy

Via its policy advocacy, Prescrire acts as a force for change in health policies, first and foremost in the interest of patients.

Français

Why You Should Be Concerned About TTIP and Access to Medicines (February 2016)

Joint Position Statement by HAI, The Commons Network and Public Citizen. The Transatlantic Trade and Investment Partnership Agreement (TTIP), now under negotiation, could hamper needed changes towards affordability, needs-driven innovation and alternative incentive structures. Read on...
 


18 February 2016

Joint Position Statement by HAI, The Commons Network and Public Citizen.

Summary

Both the European Union (EU) and the United States (US) are confronted with increasingly high medicine prices. European Member States are facing a looming access to medicines crisis as they struggle to afford new, patented, high-priced medicines. The Transatlantic Trade and Investment Partnership Agreement (TTIP), now under negotiation, could hamper needed changes towards affordability, needs-driven innovation and alternative incentive structures.

©HAI, The Commons Network, Public Citizen 2016

> Click here to download the Position Statement (pdf, 59 Ko)